OSRH logo

OSRH
OSR Holdings Inc

2,225
Mkt Cap
$17.38M
Volume
1.55M
52W High
$1.79
52W Low
$0.3803
PE Ratio
-1.38
OSRH Fundamentals
Price
$0.5195
Prev Close
$0.495
Open
$0.556
50D MA
$0.547
Beta
0.65
Avg. Volume
15.43M
EPS (Annual)
-$0.9229
P/B
0.16
Rev/Employee
$132,082.05
$63.11
Loading...
Loading...
News
all
press releases
OSRH Stock Rockets 60% On $815M Immunotherapy Deal — Retail Bulls Eye $1 Mark For The Stock
The company signed a global licensing deal with BCM Europe that could bring in up to $815 million in milestone payments.
News Placeholder
More News
News Placeholder
OSR Holdings Stock Surges Over 41% After Hours: Why Is It Moving?
OSR Holdings shares surged 41.28% after securing a global exclusive licensing deal for its Phase 3-ready cancer immunotherapy VXM01, with potential milestone payments up to $815 million.read more...
News Placeholder
Woori IO, an OSR Company, Signs NDA with Sinopharm for China Market and Global Multicenter Trials
Woori IO, an OSR Company, Signs NDA with Sinopharm for China Market and Global Multicenter Trials Woori IO, an OSR Company, Signs NDA with Sinopharm for China Market and Global Multicenter Trials PR...
News Placeholder
Why Did OSRH Stock Jump 20% Today?
The company received an additional 180-day extension from Nasdaq to regain compliance after receiving an initial notice on Sept. 9, 2025.
News Placeholder
Woori IO, an OSR Company, Highlights FDA Clarification on Non-Medical Wearables as a Catalyst for Accelerated Commercial Launch
Woori IO, an OSR Company, Highlights FDA Clarification on Non-Medical Wearables as a Catalyst for Accelerated Commercial Launch Woori IO, an OSR Company, Highlights FDA Clarification on Non-Medical...
News Placeholder
Vaximm Appoints Sbastien Wieckowski, PhD, as Chief Scientific Officer to Advance Next-Generation Oral Immunotherapy Platform
Vaximm Appoints Sbastien Wieckowski, PhD, as Chief Scientific Officer to Advance Next-Generation Oral Immunotherapy Platform Vaximm Appoints Sbastien Wieckowski, PhD, as Chief Scientific Officer to...
News Placeholder
Vaximm, an OSR Company, Receives Binding Term Sheet from BCM Europe for Global Exclusive License of VXM01 with $30M Upfront and Up to $815M in Milestones
Vaximm, an OSR Company, Receives Binding Term Sheet from BCM Europe for Global Exclusive License of VXM01 with $30M Upfront and Up to $815M in Milestones Vaximm, an OSR Company, Receives Binding Term...
News Placeholder
Woori IO Shareholders Approve Share Exchange to Become Wholly-Owned Subsidiary of OSR Holdings
Woori IO Shareholders Approve Share Exchange to Become Wholly-Owned Subsidiary of OSR Holdings Woori IO Shareholders Approve Share Exchange to Become Wholly-Owned Subsidiary of OSR Holdings PR...
News Placeholder
Vaximm AG, an OSR Company, Updates Term Sheet with BCM Europe to Shorten Exclusivity Period to Three Months
Vaximm AG, an OSR Company, Updates Term Sheet with BCM Europe to Shorten Exclusivity Period to Three Months Vaximm AG, an OSR Company, Updates Term Sheet with BCM Europe to Shorten Exclusivity Period...
News Placeholder
OSR Holdings to Present at the Emerging Growth Conference on December 10, 2025
OSR Holdings to Present at the Emerging Growth Conference on December 10, 2025 OSR Holdings to Present at the Emerging Growth Conference on December 10, 2025 PR Newswire BELLEVUE, Wash., Dec. 1, 2025...
<
1
2
...
>

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available